1663
Among the risk factors studied, two appear to increase the risk of ARE: the prescription of thiabendazole to treat strongyloidiasis during the melarsoprol cure and the bad general clinical conditions of patients.
 ( adverse event: appear to ,  increase the risk of ARE: Effect, prescription of thiabendazole: Treatment, during the melarsoprol cure: Treatment, thiabendazole: Treatment.Drug, melarsoprol: Treatment.Drug, strongyloidiasis: Treatment.Disorder) 
Locate the role in the text that participated in the event based on the event type and return it in the event list. 
 Option: Event type: adverse event,potential therapeutic event, Arguments type: Treatment.Disorder,Treatment.Time_elapsed,Treatment.Dosage,Subject.Race,Treatment.Drug,Treatment.Route,Subject.Disorder,Treatment.Freq,Treatment,Effect,Subject.Population,Treatment.Duration,Combination.Drug,Subject,Subject.Age,Subject.Gender. 
Text: {0} 
Answer:
 ( adverse event: appear to ,  increase the risk of ARE: Effect, prescription of thiabendazole: Treatment, during the melarsoprol cure: Treatment, thiabendazole: Treatment.Drug, melarsoprol: Treatment.Drug, strongyloidiasis: Treatment.Disorder) 